seeking_that

Author Archives

Hi All, A concept floated around to consolidate the merits of the stocks being discussed on biotech startups to arrive at investment sentiments which might provide guidelines, but not recommendations on investments. Gummies are responsible to take their individual decisions and benefit out of the effort put forth by KSS and team in identifying promising […]

Hi Doc, There is a teaser which talks about 3 hot companies working on pain relieving which can provide huge gains apparently. It mentions about an Arizona and Vancouver-based companies .. http://www.angelnexus.com/o/web/68345/ Google search for delta-9 gave the following companies which are doing phase3 clinical trials .. InMed Pharmaceuticals http://investorshub.advfn.com/InMed-Pharmaceuticals-Inc-IMLFF-28415/ http://www.marketwatch.com/story/inmed-pharma-proprietary-platform-growing-pipeline-low-valuation-2014-10-29 GW Pharma and Insys […]

Recent Author Comments

On Microblog: Discussion re $ARTH

Tab memory usage is a good one. Perhaps this add-on can be tried too. https://addons.mozilla.org/en-US/firefox/addon/apptelemetry/ This app gives a comprehensive time taken for different activities in loading the page. Perhaps this information [...]

Go to Comment »
On Profits Unlimited's "$7 Tech Stock" and the "strange industry expected to surge 8,000%"

Thanks[...]

Go to Comment »
On Profits Unlimited's "$7 Tech Stock" and the "strange industry expected to surge 8,000%"

Hi Trevis, Could you please take a look at this article and give your opinion ? Things might change. https://globenewswire.com/news-release/2016/08/01/860508/10164353/en/STMicroelectronics-Earns-MEMS-Manufacturer-of-the-Year-Award.html SHANGHAI, China[...]

Go to Comment »
On Microblog: Discussion re $ARTH

Will the commercialization of the product have to wait for the patents to be approved ? If it takes more time for the patents to be approved, can they go to the market with patent pending status ? Probably they are timing the filing of patents to coincid[...]

Go to Comment »
On Microblog: Discussion re $ARTH

Another reference to the sales vs production cost, but not quantified though. All that google could provide during the search, if it helps ... http://archtherapeutics.blogspot.in/ 5) Potentially extraordinary gross profit margins—At scale $ 400-[...]

Go to Comment »
On Microblog: Discussion re $ARTH

They have a pdf download as well http://www.redchip.com/assets/reports/ARTH_FactSheet_20150518.pdf[...]

Go to Comment »
On Microblog: Discussion re $ARTH

Cost of AC5 solutions Perhaps it came from RedChip interview. Norchi also mentions in the interview that one of the value propositions of AC5 is "High Margins and Low Cost to Market" http://www.redchip.com/company/home/ARTH/257/healthcare Investment[...]

Go to Comment »
On Microblog: Discussion re $ARTH

This agency says 9-week period CE mark approval for a medical device with its FastTrack programmes: http://www.bsigroup.com/en-GB/medical-devices/our-services/ce-marking-speed-to-market/ More info on CE approval for medical devices http://www.emergo[...]

Go to Comment »
On Microblog: Discussion re $ARTH

Excellent ! So technically we are close to end of phase I http://www.stockgumshoe.com/2015/03/microblog-primer-on-drug-development/ As was reiterated this being a medical device should complete the process faster I hope.[...]

Go to Comment »
On Microblog: Discussion re $ARTH

I know. I have been following these articles. But we are dealing with human minds and emotions. It needs confirmation from different sources no matter how solid the foundation was laid here. Quoting from different reliable sources leading to the same con[...]

Go to Comment »
On Microblog: Discussion re $ARTH

Not sure how to read the assets and liabilities table. But if there cash assets are $ 1.6 m, with CURAM doubly matching Arch's spending and their judicious spending, they may well be able to get past the financial hurdle ($ 3m) for human trials to get C[...]

Go to Comment »
On Microblog: Discussion re $ARTH

Might be worth reading this article on seekingalpha - positive on Arch with good pros and cons analysis http://seekingalpha.com/article/3964460-tiny-arch-therapeutics-just-doubled-time-dump[...]

Go to Comment »
On Microblog: Saving Jack Kerouac

Thanks Curt. Further clarification is much appreciated. Is the success of ARTH still to be viewed as a binary event ? I suppose the grant of medical device designation reduces the risk factor. Does the grant entitle ARTH to proceed further with commerci[...]

Go to Comment »
On Microblog: Saving Jack Kerouac

Hi Doc, I had to move to a new place for a project. Yet to catch up with the developments happening around here. I received the following notification from Arch therapeutics. Sounds positive to me. How far off is in the evaluation process without hu[...]

Go to Comment »
On The 2015 Stock Gumshoe Biotechnology Awards Show!

Can anyone explain why the biotech stocks are going down today ?[...]

Go to Comment »
On The 2015 Stock Gumshoe Biotechnology Awards Show!

TRIL @ 13.75, kpti @ 26.24[...]

Go to Comment »
On The 2015 Stock Gumshoe Biotechnology Awards Show!

Good review on bloomberg .. http://www.bloomberg.com/news/2015-01-20/shake-shack-seeks-up-to-80-million-ipo-of-meyer-s-burger-chain.html[...]

Go to Comment »
On The 2015 Stock Gumshoe Biotechnology Awards Show!

thanks doc[...]

Go to Comment »
On The 2015 Stock Gumshoe Biotechnology Awards Show!

Hi Doc, Zosano is offering IPO shares on Jan 26th. It struck a deal with NVO on type 2 diabetes in Feb '14 http://www.bizjournals.com/sanfrancisco/blog/biotech/2014/02/zosano-novo-nordisk-diabetes-patch.html?page=all and in november it signed a p[...]

Go to Comment »
On DailyWealth Trader... "recommended going long a special gold fund"

Thanks a lot Ben .. I just registered myself to this newsletter .. I am happy I could be of some help Regards, s_t[...]

Go to Comment »

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info